FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1384 October 24, 2002 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Paromomycin and diloxanide furoate are the drugs recommended for the treatment of asymptomatic Entamoeba histolytica infection.¹ These agents have been used in clinical practice for more than 30 years. The efficacy of either agent against E. histolytica is reported to be greater than 80 percent,² although some have suggested that paromomycin is preferable because of a lower cure rate reported with the use of diloxanide furoate in symptomatic patients.³ However, the efficacy of these medications was evaluated before the identification of E. dispar as a separate nonpathogenic species, which is morphologically indistinguishable from E. histolytica and which . . . [Full Text of this Article]

This article has been cited by other articles:

• (2006). Answer. Gut 55: 841-841 [Full Text]  
• Nowak, N., Lotter, H., Tannich, E., Bruchhaus, I. (2004). Resistance of Entamoeba histolytica to the Cysteine Proteinase Inhibitor E64 Is Associated with Secretion of Pro-enzymes and Reduced Pathogenicity. J. Biol. Chem. 279: 38260-38266 [Abstract] [Full Text]  
• Blessmann, J., Ali, I. K. M., Ton Nu, P. A., Dinh, B. T., Ngo Viet, T. Q., Le Van, A., Clark, C. G., Tannich, E. (2003). Longitudinal Study of Intestinal Entamoeba histolytica Infections in Asymptomatic Adult Carriers. J. Clin. Microbiol. 41: 4745-4750 [Abstract] [Full Text]  
• Haque, R., Huston, C. D., Hughes, M., Houpt, E., Petri, W. A. Jr. (2003). Amebiasis. NEJM 348: 1565-1573 [Full Text]